Moolec Science (MLEC) Income from Continuing Operations (2022 - 2024)

Moolec Science's (MLEC) quarterly Income from Continuing Operations came in at 1865529.0 in Q4 2024, up 17.29% year-on-year from 1590531.37 in Q1 2024, and up 5.37% quarter-over-quarter from 1971477.0 in Q3 2024.

Moolec Science (MLEC) Income from Continuing Operations (2022 - 2024) Analysis & Trends

Moolec Science has disclosed Income from Continuing Operations across 3 years of filings, most recently posting 1865529.0 for Q4 2024.

  • Income from Continuing Operations for Q4 2024 came in at 1865529.0, up 17.29% year-over-year; the trailing twelve-month figure through Dec 2024 was 32943487.0 (down 134.6% YoY), and the FY2024 annual result was 27958152.0, down 155.04% from the prior year.
  • Income from Continuing Operations came in at 1865529.0 for Q4 2024 at Moolec Science, up from 1971477.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 99835094.0 in Q2 2023 to a low of 27958152.0 in Q2 2024.
  • The 3-year median for Income from Continuing Operations is 1516328.0 (2022), against an average of 8780510.67.
  • Across the five-year window, Income from Continuing Operations soared 3470.4% in 2023 and tumbled 220.25% in 2024, its largest moves.
  • Moolec Science's Income from Continuing Operations stood at 47960848.0 in 2022, then slumped by 104.7% to 2255497.0 in 2023, then gained by 17.29% to 1865529.0 in 2024.
  • The last three Income from Continuing Operations figures came in at 1865529.0 (Q4 2024), 1971477.0 (Q3 2024), and 27958152.0 (Q2 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - -
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - -26.94 Mn
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - -2.97 Mn
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn 30.80 Mn
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - -14.46 Mn
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - -3.40 Mn
7 Psyence Biomedical 241.78 Bn 241.78 Bn - -1.50 Mn
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn 1.03 Bn
9 Abivax 94.26 Bn 94.26 Bn - -56.48 Mn
10 Moolec Science 6.98 Bn 6.98 Bn - -

Historic Data

Download Data
DateValue
Dec 31, 2024 -1.87 Mn
Sep 30, 2024 -1.97 Mn
Jun 30, 2024 -27.96 Mn
Mar 31, 2024 -1.15 Mn
Dec 31, 2023 -2.26 Mn
Sep 30, 2023 -2.02 Mn
Jun 30, 2023 99.84 Mn
Mar 31, 2023 -358,578.00
Dec 31, 2022 47.96 Mn
Sep 30, 2022 -721,426.00
Jun 30, 2022 -2.96 Mn
Mar 31, 2022 -1.17 Mn